iLAC
Tsukuba
About iLAC
iLAC uses genome analysis systems to diagnose diseases based on scientific evidence. They promote and realize precision medicine, which leads to the selection of the suitable treatment and medicine for each individual.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Mar 2020)
- Website: i-lac.co.jp
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/ilac-1009919 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.